✦ LIBER ✦

Characteriation of Clinical Data Packages Using Foreign Data in New Drug Applications in Japan

✍ Scribed by Tanaka, M; Nagata, T

Book ID: 110020202
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 120 KB
Volume: 84
Category: Article
ISSN: 0009-9236
DOI: 10.1038/sj.clpt.6100346

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Application of land use regression to re

Application of land use regression to regulatory air quality data in Japan

✍ Saori Kashima; Takashi Yorifuji; Toshihide Tsuda; Hiroyuki Doi 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 471 KB

Use of compassionate-case ATMP in precli

Use of compassionate-case ATMP in preclinical data for clinical trial applications

✍ Mark W Lowdell; Martin Birchall; Adrian J Thrasher 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 38 KB

PMC5 ARE THE BEST AVAILABLE, MOST APPLIC

PMC5 ARE THE BEST AVAILABLE, MOST APPLICABLE CLINICAL EFFECTIVENESS DATA USED IN ECONOMIC EVALUATIONS OF DRUG THERAPIES?

✍ MF Drummond; B Hanratty; J Nixon; J Christie 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Inclusion of human intravenous study dat

Inclusion of human intravenous study data in new drug applications—impact of the japanese guidance

✍ Haruo Imawaka; Makiko Kusama; Kiyomi Ito; Shunsuke Ono; Yuichi Sugiyama 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

Standards of basal metabolism of girls (

Standards of basal metabolism of girls (new data) and their use in clinical practice

✍ Fritz B. Talbot; Edwin B. Wilson; Jane Worcester 📂 Article 📅 1935 🏛 Elsevier Science 🌐 English ⚖ 436 KB

Age disparity between a cancer populatio

Age disparity between a cancer population and participants in clinical trials submitted as a new drug application of anticancer drugs in Japan

✍ Akiko Hori; Taro Shibata; Masahiro Kami; Eiji Kusumi; Hiroto Narimatsu; Yukiko K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract ## BACKGROUND. Underrepresentation of older patients in cancer clinical trials has been reported previously. ## METHODS. To evaluate disparities in age between actual cancer patients and those enrolled in clinical trials, the authors examined all the review reports of the Pharmaceuti